C12N 2795/12032
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2795/12032 (Use of virus as therapeutic agent, other than vaccine) appears on 2 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 4
- Assignees
- 5
- Inventors
- 39
- Latest grant
- 24 Aug 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
By publication year.
Recent patents
- Fusobacterium bacteriophage and uses thereof7 Dec 2023US 2023/0390349 A1Biomx Ltd.
- Bacteriophage compositions and uses thereof9 Mar 2023US 2023/0074892 A1Yale University
- Virulent pseudomonas fluorescens phage pf1901, and phage pf1901 preparation and application thereof28 Jan 2021US 2021/0024899 A1Bohai University
- Bacteriophages expressing antimicrobial peptides and uses thereof19 Feb 2015US 2015/0050717 A1Massachusetts Institute of Technology
Most cited
By later US patents